Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
15Activity
0 of .
Results for:
No results containing your search query
P. 1
MAPS Bulletin, Fall 2009, Annual Report

MAPS Bulletin, Fall 2009, Annual Report

Ratings: (0)|Views: 1,001 |Likes:
Published by Projekt E 012
Fall 2009 Vol. 19, No. 3 MAPS Annual Report 2009

The MAPS Bulletin is published by the Multidisciplinary Association for Psychedelic Studies. It first appeared as the MAPS Newsletter, a one page letter in 1988. In 1995, after growing successively longer with each issue, the "Newsletter" became the MAPS Bulletin. Some issues also began featuring color covers.

The Bulletin is published tri-annually, and all MAPS members recieve a complimentary suscription. MAPS also distributes the Bulletin as an educational tool to about 400 scientists, government officials, drug war prisoners, and influential academics.

Interested parties wishing to copy any portion of these articles are encouraged to do so and are kindly requested to credit MAPS, including name and address. The Bulletin is produced by a small group of dedicated staff and volunteers focused primarily on assisting scientists to conduct human studies to generate essential information about the risks and psychotherapeutic benefits of MDMA, other psychedelics, and marijuana, with the goal of eventually gaining government approval for their medical uses.

Free Cultural Work - A Creative Commons Attribution
You are free: to share, to copy, distribute and transmit
this information under the following conditions:
• Attribution. You must attribute the work in the
manner specifed by the author or licensor (but not
in any way that suggests that they endorse you
or your use of the work).
What does “Attribute this work” mean?
• For any reuse or distribution, you must make clear to
others the license terms of this work. The best way to
do this is with a link to our web page: www.maps.org
• Any of the above conditions can be waived if you
get permission from the copyright holder.
• Nothing in this license impairs or restricts the
author’s moral rights.
Your fair dealing and other rights are in no way
affected by the above.
Fall 2009 Vol. 19, No. 3 MAPS Annual Report 2009

The MAPS Bulletin is published by the Multidisciplinary Association for Psychedelic Studies. It first appeared as the MAPS Newsletter, a one page letter in 1988. In 1995, after growing successively longer with each issue, the "Newsletter" became the MAPS Bulletin. Some issues also began featuring color covers.

The Bulletin is published tri-annually, and all MAPS members recieve a complimentary suscription. MAPS also distributes the Bulletin as an educational tool to about 400 scientists, government officials, drug war prisoners, and influential academics.

Interested parties wishing to copy any portion of these articles are encouraged to do so and are kindly requested to credit MAPS, including name and address. The Bulletin is produced by a small group of dedicated staff and volunteers focused primarily on assisting scientists to conduct human studies to generate essential information about the risks and psychotherapeutic benefits of MDMA, other psychedelics, and marijuana, with the goal of eventually gaining government approval for their medical uses.

Free Cultural Work - A Creative Commons Attribution
You are free: to share, to copy, distribute and transmit
this information under the following conditions:
• Attribution. You must attribute the work in the
manner specifed by the author or licensor (but not
in any way that suggests that they endorse you
or your use of the work).
What does “Attribute this work” mean?
• For any reuse or distribution, you must make clear to
others the license terms of this work. The best way to
do this is with a link to our web page: www.maps.org
• Any of the above conditions can be waived if you
get permission from the copyright holder.
• Nothing in this license impairs or restricts the
author’s moral rights.
Your fair dealing and other rights are in no way
affected by the above.

More info:

Published by: Projekt E 012 on Nov 18, 2009
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

01/16/2014

pdf

text

original

 
VOLUME XIX NUMBER 3
MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES
2009 Annual Report
 
A ContinuingMedicalEducationConference
 
Psychedelic
SCIENCE
IN THE
Century
Twenty-frst
San Jose, CA
APRIL
 15
~
18
2010
Psychedelic Science in the 21st Century 
 A Continuing Medical Education (CME) Conference
with concurrent presentations in a non-CME track
For physicians, medical & therapeutic proessionals
and 
the general public.
 April 15-18, 2010 • San Jose, California
 
Presented by the Multidisciplinary Association for Psychedelic Studies (MAPS)
Featuring presentations by:
 co-founder of transpersonal psychology
Stanislav Grof, M.D.
 
consciousness researcher & psychotherapist
 
Ralph Metzner, Ph.D.
visionary artists
 Alex and Allyson Grey 
 founders of Erowid.org
Earth and Fire Erowid
 pharmacologist & chemist
 Alexander “Sasha” Shulgin, Ph.D.
 
integrative medicine proponent
 Andrew Weil, M.D.
 
Matt Baggott, Ph.D. Candidate, (UC Berkeley, LSD, MDMA, MDA, salvia divinorum researcher)
Jose Carlos Bouso, Ph.D. Candidate (Spain, MDMA/PTSD researcher)Alicia Danorth, Ph.D. Candidate (ITP, UCLA psilocybin researcher)Rick Doblin, Ph.D. (executive director & ounder o MAPS)Frank Echenhoer, Ph.D. (Caliornia Institute o Integral Studies)James Fadiman, Ph.D. (Institute o Transpersonal Psychology)Amanda Feilding, (Director o The Beckley Foundation)Peter Gasser, M.D. (Switzerland, LSD/end-o-lie anxiety researcher)Neal Goldsmith, Ph.D. (author, psychotherapist)Roland Grifths, Ph.D. (JHU, psilocybin/mystical experiences researcher)Charles Grob, M.D. (UCLA, psilocybin/cancer anxiety researcher)John Halpern, M.D.
by video link (Harvard, neurocognitive consequences of ecstasy researcher)
Julie Holland, M.D. (NYU School o Medicine, psychiatric emergency services)Sergio Marchevsky, M.D. (Israel, MDMA/PTSD researcher)John Mendelson, M.D. (CPMC RI, LSD, MDMA, MDA, salvia divinorum researcher)Michael Mithoeer, M.D. (U.S., MDMA/PTSD researcher)Francisco Moreno, M.D. (Psilocybin/OCD researcher)David Nichols, Ph.D. (Heter Research Institute, Purdue University)Peter Oehen, M.D. (Switzerland, MDMA/PTSD researcher)Ingrid Pacey, M.D. (Canada, MDMA/PTSD researcher)Torsten Passie, M.D., Ph.D. (Germany, psilocybin research)Tom Pinkson, Ph.D. (psychotherapist)Jordi Riba, Ph.D. (Spain, ayahuasca researcher)William Richards, Ph.D. (JHU, psilocybin/cancer anxiety researcher)Thomas Roberts, Ph.D. (Northern Illinois University)Stephen Ross, M.D. (NYU, psilocybin/cancer anxiety researcher)Ben Sessa, M.D. (UK, psilocybin researcher)Franz Vollenweider, M.D. (Switzerland, psychedelic neuroscience researcher)Michele Weitz, B.A. (U.S., clinical research expert)Others yet to be announced
Pre- and post-conference workshops with Alex & Allyson Grey, Stanislav Grof, M.D.,Rick Doblin, Ph.D., Michael Mithoefer, M.D., Annie Mithoefer, B.S.N. and others.
Information & registration:
www.maps.org/conference or call 831-429-6362
Presented by the Multidisciplinary Association for PsychedelicStudies (MAPS)
This activity has been planned and implemented in accordance with the Institute or Medical Quality and the Caliornia Medical Association’s CME Accreditation Standards (IMQ/CMA) through the Joint-Sponsorship o CME Consultants and theMultidisciplinary Association or Psychedelic Studies (MAPS). CME Consultants is accredited by IMQ/CMA to provide continuing medical education or physicians. CME Consultants takes responsibility or the content, quality and scientifc integrity o this CMEactivity.CME Consultants designates this educational activity or a maximum o 15.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent o their participation in the activity. This credit may also be applied to the CMA.
M
 A
PS
MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC
 
maps • volume xix number 3 • winter 2oo9~1o
1
MAPS
(Multidisciplinary Association or PsychedelicStudies) is a membership-based organization. Founded in1986,
MAPS is an IRS approved 501 (c)(3) non-proftcorporation unded by tax deductible donations
.Our mission is 1) to treat conditions or which convention-al medicines provide limited relie—such as posttraumaticstress disorder (PTSD), pain, drug dependence, anxietyand depression associated with end-o-lie issues—bydeveloping psychedelics and marijuana into prescrip-tion medicines; 2) to cure many thousands o people bybuilding a network o clinics where treatments can beprovided; and 3) to educate the public honestly about therisks and benefts o psychedelics and marijuana.Interested parties wishing to copy any portion othis publication are encouraged to do so and are kindlyrequested to credit MAPS and include our address. TheMAPS Bulletin is produced by a small group o dedicatedsta and volunteers.
 Your participation, fnancial orotherwise, is welcome.
 2009 Multidisciplinary Associationfor Psychedelic Studies, Inc.MAPS309 Cedar Street, #2323, Santa Cruz, CA 95060Phone: 831-429-6362Fax: 831-429-6370E-mail: askmaps@maps.orgWeb: www.maps.org
Editor: Randolph Hencken, M.A.Design/Build: Noah Juan JuneauISSN 1080-8981Visit maps.org/catalog for informationabout donations and purchasesPrinted on recycled paper
Free Cultural Work - A Creative Commons Attribution
 You are ree: to share, to copy, distribute and transmitthis inormation under the ollowing conditions:
*Attribution
. You must attribute the work in themanner specifed by the author or licensor (but notin any way that suggests that they endorse youor your use o the work).
What does “Attribute this work” mean?
 * For any reuse or distribution, you must make clear toothers the license terms o this work. The best way todo this is with a link to our web page: www.maps.org* Any o the above conditions can be waived i youget permission rom the copyright holder.* Nothing in this license impairs or restricts theauthor’s moral rights. Your air dealing and other rights arein no way aected by the above.
1
CONTENTS Winter 2009
2
 Annual Financial Report
by Rick Doblin, Ph.D.15
MAPS’ Research: A Year in Review
by Valerie Mojeiko, B.A.18
Psychedelic Science in the 21st Century Conerence:
The PreeminentConerence on Psychedelic Research and Psychedelic Psychotherapyby Randolph Hencken, M.A.20
Psychedelic Outreach in the Inormation Age
by Brian Wallace22
O Prickles and Goo:
How MAPS is Redefning the Science o Spirituality
 
by Brad Burge, Ph.D. student24
Exploring the World o Ayahuasca-Based Tourism and the Globalization o Psychedelics:
 A Review o Two New Books rom Rak Razamby David Jay Brown, M.A.27
Who We Are:
MAPS Sta 28
Membership
page 
Covers:
See page 26 or descriptions and artists’ statments
In terms o our mission,FY 08-09 was ourbest year to date,MAPS gatheredsubstantially more datathan ever beore,and gained more experiencedesigning, obtaining approval or,unding, conducting,monitoring, and evaluatingpsychedelic psychotherapyclinical trials.

Activity (15)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads
Pedro liked this
Pedro liked this
banarisali liked this
wawawa2 liked this
Ingledsva liked this

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->